Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.

Saved in:
Bibliographic Details
Title: Prophylactic Hydroxyurea Treatment Is Associated with Improved Cerebral Hemodynamics as a Surrogate Marker of Stroke Risk in Sickle Cell Disease: A Retrospective Comparative Analysis.
Authors: Peine, Brian R.1 (AUTHOR) calla1mu@cmich.edu, Callaghan, Michael U.1,2 (AUTHOR) aglaros@dmc.org, Callaghan, Joseph H.3 (AUTHOR) callaghan1954@gmail.com, Glaros, Alexander K.1,2 (AUTHOR)
Source: Journal of Clinical Medicine. Jun2022, Vol. 11 Issue 12, p3491. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20770383
DOI:10.3390/jcm11123491